Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shree Pacetronix's revenue for the
three
months ended in Jun. 2026 was ₹49.0 Mil.
Its revenue for the trailing twelve months (TTM) ended in Jun. 2026 was ₹211.9 Mil.
Shree Pacetronix's Revenue per Share for the
three
months ended in Jun. 2026 was ₹12.57.
Its Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ₹57.39.
Good Sign:
Shree Pacetronix Ltd has shown predictable revenue and earnings growth.
During the past 12 months, the average Revenue per Share Growth Rate of Shree Pacetronix was 20.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 1.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 22.10% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 13.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.
During the past 13 years, Shree Pacetronix's highest 3-Year average Revenue per Share Growth Rate was 42.90% per year. The lowest was -3.20% per year. And the median was 4.60% per year.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Shree Pacetronix Revenue Related Terms
Shree Pacetronix Revenue Historical Data
* Premium members only.
The historical data trend for Shree Pacetronix's Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Shree Pacetronix's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shree Pacetronix Revenue vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shree Pacetronix's Revenue distribution charts can be found below:
* The bar in red indicates where Shree Pacetronix's Revenue falls into.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Revenue for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹211.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shree Pacetronix (BOM:527005) has a Revenue of ₹211.9 Mil as of Jun. 2026. Revenue is the total amount a company generates as sales through its operations. View historical data on Shree Pacetronix and its competitors.
Is Shree Pacetronix's Revenue too high?
Shree Pacetronix's current Revenue is ₹211.9 Mil. Overall, Shree Pacetronix has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shree Pacetronix's Revenue compare to ISRG and BDX?
Shree Pacetronix's Revenue of ₹211.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue for a Medical Devices & Instruments company?
A good Revenue depends on the Medical Devices & Instruments industry context. However, Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue mean?
A high Revenue can signal that a stock is expensive relative to its fundamentals. Revenue is the total amount a company generates as sales through its operations. View historical data on Shree Pacetronix and its competitors. Shree Pacetronix's current Revenue is ₹211.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shree Pacetronix stock overvalued right now?
Based on GuruFocus' analysis, Shree Pacetronix (BOM:527005) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹153.14, compared to a current price of ₹136.25 — trading 11% below its estimated fair value. The current Revenue is ₹211.9 Mil. Shree Pacetronix's overall GF Score™ is 82/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue calculated?
Revenue is calculated from a company's financial statements. For Shree Pacetronix (BOM:527005), the current Revenue is ₹211.9 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shree Pacetronix (BOM:527005) Overvalued in 2026?
Based on GuruFocus' analysis, Shree Pacetronix stock appears to be undervalued.
The current stock price of ₹136.25 is trading 11% below its estimated GF Value™ of ₹153.14.
GuruFocus considers Shree Pacetronix to be Modestly Undervalued.
Key valuation signals for BOM:527005:
Revenue: ₹211.9 Mil
GF Value™: ₹153.14 vs. price of ₹136.25 (11% below fair value)
No single metric tells the full story. See the BOM:527005 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shree Pacetronix Ltd is engaged in the manufacturing of medical and surgical equipment and orthopedic appliances. It is in the business of manufacturing and selling Implantable Cardiac Pacemakers. Pacemakers are anti-bradycardia implantable devices intended for permanent ventricular or atrial pacing applications. The Company is engaged in only one segment i.e. Life Saving Devices. It sells its life-saving devices in India and internationally, of which the majority of revenue is generated from the sales made in India.
82GF Score
Get the complete analysis for BOM:527005
Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:527005 has been successfully added to your 
